- Researchers from MSKCC reported results of the first clinical trial ever to show that a drug helped patients with advanced uveal melanoma at the American Society of Clinical Oncology Meeting in Chicago.
- MSKCC’s Charles L. Sawyers, MD, was this year’s recipient of the ASCO Science of Oncology Award.
- Carol Aghajanian of MSKCC was quoted in a Bloomberg article about a simple screening program for cervical cancer using vinegar and visual exams.
- Jedd Wolchok of MSKCC is quoted in a Nature article about the possibility of combination approaches expanding the number of cancers that respond to immunotherapy.
- Sotheby’s auctioneer and raconteur Jamie Niven was the guest of honor at a dinner hosted by the Society of Memorial Sloan-Kettering Cancer Center.
Author Archives: Mark
MSKCC in the News: April 25 – May 14
- Christopher Lima of MSKCC was selected to join the Howard Hughes Medical Institute Investigator Program.
- Gopa Iyer of MSKCC was awarded the James Family Young Investigator Award for “Identifying Predictors of Response to mTOR-targeted Therapies in Bladder Cancer.”
- Foundation Medicine and MSKCC announced a partnership that brings together clinical, genomic and computational expertise to advance patient care in hematologic cancers.
- Scientists from The Children’s Hospital of Philadelphia and MSKCC published results in the journal Cell Stem Cell of a new model cell system that allows neuroscientists to investigate normal brain development, as well as to identify specific disruptions in biological signals that may contribute to neuropsychiatric diseases.
- Nature published findings from a large-scale genomic analysis led by researchers at MSKCC and other centers within The Cancer Genome Atlas (TCGA) Research Network that may help diagnose endometrial cancer and lead to new drug development.
- MSKCC’s Dr. Kenneth Offit is quoted in an NPR article about Angelina Jolie’s decision to have a preventive double mastecomy.
MSKCC in the News: April 3 – April 24
- MSKCC is profiled in a New York Times article about major academic medical centers in New York and around the country that are spending and recruiting heavily on genomic sequencing programs.
- Researchers from Cornell and MSKCC have published results of a study that revealed that spongelike nanoparticles whose pores can be filled with drugs may offer the promise of drug delivery to specific targets in the body.
- Genetically engineered immune cells can drive an aggressive type of leukemia into retreat, an MSKCC clinical trial suggests.
- Charles Sawyers of MSKCC is quoted in a Nature article advocating for cancer researchers to focus on single-subject, or ‘n-of-1’, studies that could offer new insights into cancer.
- A new study published in the British Medical Journal from researchers at MSKCC suggest that aside from men with a history of prostate cancer, other groups at high risk for the disease may be identified with a single PSA test when they are in their 40s.